0001127602-20-023070.txt : 20200806
0001127602-20-023070.hdr.sgml : 20200806
20200806165349
ACCESSION NUMBER: 0001127602-20-023070
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200805
FILED AS OF DATE: 20200806
DATE AS OF CHANGE: 20200806
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Clyburn Frank
CENTRAL INDEX KEY: 0001763963
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-06571
FILM NUMBER: 201082469
MAIL ADDRESS:
STREET 1: 2000 GALLOPING HILL ROAD
CITY: KENILWORTH
STATE: NJ
ZIP: 07033
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Merck & Co., Inc.
CENTRAL INDEX KEY: 0000310158
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 221918501
STATE OF INCORPORATION: NJ
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2000 GALLOPING HILL ROAD
CITY: KENILWORTH
STATE: NJ
ZIP: 07033
BUSINESS PHONE: 908-740-4000
MAIL ADDRESS:
STREET 1: 2000 GALLOPING HILL ROAD
CITY: KENILWORTH
STATE: NJ
ZIP: 07033
FORMER COMPANY:
FORMER CONFORMED NAME: Merck & Co. Inc.
DATE OF NAME CHANGE: 20091103
FORMER COMPANY:
FORMER CONFORMED NAME: SCHERING PLOUGH CORP
DATE OF NAME CHANGE: 19920703
4
1
form4.xml
PRIMARY DOCUMENT
X0306
4
2020-08-05
0000310158
Merck & Co., Inc.
MRK
0001763963
Clyburn Frank
MERCK & CO., INC.
2000 GALLOPING HILL ROAD
KENILWORTH
NJ
07033
1
EVP, Chief Commercial Officer
Common Stock
2020-08-05
4
M
0
18876
0
A
99639.106
D
Common Stock
2020-08-05
4
S
0
18876
81.5466
D
80763.106
D
Common Stock - 401(k) Plan
1629.2567
I
By 401(k)
Stock Option (Right to Buy)
39.29
2020-08-05
4
M
0
18876
0
D
2013-05-02
2022-05-01
Common Stock
18876
0
D
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $81.5400 to $81.5550, inclusive. The reporting person undertakes to provide to Merck & Co., Inc., any security holder of Merck & Co., Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above in this footnote.
Holdings include shares acquired in dividend reinvestment transactions.
Includes shares acquired and dividends earned through July 7, 2020, in the Merck U.S. Savings Plan, a 401(k) plan.
The option became exercisable in equal installments on 5/2/2013, 5/2/2014 and 5/2/2015.
/s/ Faye C. Brown as Attorney-in-Fact for Frank Clyburn
2020-08-06